Skip to content

Important safety information

Prescribing information

This site is intended for US
patients only.

What is Severe Primary
IGF-1 Deficiency?
About
INCRELEX^®
Staying on
Treatment
Eton Cares
Helpful
Resources

What is Severe Primary
IGF-1 Deficiency?
About
INCRELEX^®
Staying on
Treatment
Eton Cares
Helpful
Resources

What is Severe Primary
IGF-1 Deficiency?
About
INCRELEX^®
Staying on
Treatment
Eton Cares
Helpful
Resources

What is Severe Primary
IGF-1 Deficiency?
About
INCRELEX^®
Staying on
Treatment
Eton Cares
Helpful
Resources

Important safety information

Prescribing information

This site is intended for US
patients only.

Author: increlex_admin

INCRELEX® and Eton Cares Program® are registered trademarks of Eton Pharmaceuticals, Inc. Eton is a trademark of Eton Pharmaceuticals, Inc.

What is Severe Primary
IGF-1 Deficiency?
About
INCRELEX^®
Staying on
Treatment
Eton Cares
Helpful
Resources

What is Severe Primary
IGF-1 Deficiency?
About
INCRELEX^®
Staying on
Treatment
Eton Cares
Helpful
Resources

About Eton Pharmaceuticals
Terms of Use
Privacy policy
Contact us

© 2026 Eton Pharmaceuticals, Inc. All rights reserved. 1887-v8

NOTE: You are about to leave an Eton Pharmaceuticals website. This link is provided as a service to our website visitors. It will take you to another site maintained by Eton Pharmaceuticals.